Teva faces fish oil patent complaint

16-10-2017

Irish biopharmaceutical company Amarin has continued a patent battle over its fish oil product Vascepa (icosapent ethyl), with a lawsuit targeting Teva in Nevada.


Teva, fish oil, patent, Amarin, Vascepa (icosapent ethyl)

More on this story

Amarin suffers defeat over Vascepa patents
01-04-2020

LSIPR